MxiA, MxiC and IpaD Regulate Substrate Selection and Secretion Mode in the T3SS of <i>Shigella flexneri</i>

Type III secretion systems (T3SSs) are central virulence devices for many Gram-negative bacterial pathogens of humans, animals & plants. Upon physical contact with eukaryotic host cells, they translocate virulence-mediating proteins, known as effectors, into them during infection. T3SSs are gated from the outside by host-cell contact and from the inside via two cytoplasmic negative regulators, MxiC and IpaD in Shigella flexneri, which together control the effector secretion hierarchy. Their absence leads to premature and increased secretion of effectors. Here, we investigated where and how these regulators act. We demonstrate that the T3SS inner membrane export apparatus protein MxiA plays a role in substrate selection. Indeed, using a genetic screen, we identified two amino acids located on the surface of MxiA's cytoplasmic region (MxiAC) which, when mutated, upregulate late effector expression and, in the case of MxiAI674V, also secretion. The cytoplasmic region of MxiA, but not MxiAN373D and MxiAI674V, interacts directly with the C-terminus of MxiC in a two-hybrid assay. Efficient T3S requires a cytoplasmic ATPase and the proton motive force (PMF), which is composed of the ΔΨ and the ΔpH. MxiA family proteins and their regulators are implicated in utilization of the PMF for protein export. However, our MxiA point mutants show similar PMF utilisation to wild-type, requiring primarily the ΔΨ. On the other hand, lack of MxiC or IpaD, renders the faster T3S seen increasingly dependent on the ΔpH. Therefore, MxiA, MxiC and IpaD act together to regulate substrate selection and secretion mode in the T3SS of Shigella flexneri

The Architecture of the Cytoplasmic Region of Type III Secretion Systems

Type III secretion systems (T3SSs) are essential devices in the virulence of many Gram-negative bacterial pathogens. They mediate injection of protein effectors of virulence from bacteria into eukaryotic host cells to manipulate them during infection. T3SSs involved in virulence (vT3SSs) are evolutionarily related to bacterial flagellar protein export apparatuses (fT3SSs), which are essential for flagellar assembly and cell motility. The structure of the external and transmembrane parts of both fT3SS and vT3SS is increasingly well-defined. However, the arrangement of their cytoplasmic and inner membrane export apparatuses is much less clear. Here we compare the architecture of the cytoplasmic regions of the vT3SSs of Shigella flexneri and the vT3SS and fT3SS of Salmonella enterica serovar Typhimurium at ~5 and ~4 nm resolution using electron cryotomography and subtomogram averaging. We show that the cytoplasmic regions of vT3SSs display conserved six-fold symmetric features including pods, linkers and an ATPase complex, while fT3SSs probably only display six-fold symmetry in their ATPase region. We also identify other morphological differences between vT3SSs and fT3SSs, such as relative disposition of their inner membrane-attached export platform, C-ring/pods and ATPase complex. Finally, using classification, we find that both types of apparatuses can loose elements of their cytoplasmic region, which may therefore be dynamic

Association of sleep duration and sleep quality with the risk of metabolic syndrome in adults: a systematic review and meta-analysis

Introduction: The association between sleep duration and metabolic syndrome (MetS) remains controversial, and few have considered the effects of sleep quality. We performed a meta-analysis to clarify the relationship of sleep duration and sleep quality with the risk of MetS. Material and methods: We conducted a systematic and comprehensive literature search of electronic databases from inception to 17 February 2022. The effect sizes of covariates from each study were pooled using a random or fixed model, and a restricted cubic spline random-effects meta-analysis was performed to examine the dose-response relationship between sleep duration and MetS. Results: A total of 62 studies were included in this meta-analysis. Compared to normal sleep duration, short sleep duration [odds ratio (OR) = 1.14, 95% confidence interval (CI): 1.10–1.19] and long sleep duration (OR = 1.15, 95% CI: 1.09–1.23) were associated with an increased risk of MetS. The restricted cubic spline analysis indicated that sleep durations of 8.5 h (OR = 0.95, 95% CI: 0.92–0.97) and 11 h (OR = 1.58, 95% CI: 1.31–1.91) were significantly associated with the risk of MetS. The pooled results showed that poor sleep quality (OR = 1.46, 95% CI: 1.03–2.06) and sleep complaints had significant positive associations with MetS. Conclusion: Our results demonstrated that short sleep duration increased the risk of developing MetS. Long sleep duration was also associated with MetS, especially for 11 h. 8.5 h can be considered the recommended sleep duration for MetS. Poor sleep quality and sleep complaints were also associated with MetS

Increased CD45RA+FoxP3low Regulatory T Cells with Impaired Suppressive Function in Patients with Systemic Lupus Erythematosus

BACKGROUND: The role of naturally occurring regulatory T cells (Treg) in the control of the development of systemic lupus erythematosus (SLE) has not been well defined. Therefore, we dissect the phenotypically heterogeneous CD4(+)FoxP3(+) T cells into subpopulations during the dynamic SLE development. METHODLOGY/PRINCIPAL FINDINGS: To evaluate the proliferative and suppressive capacities of different CD4(+) T cell subgroups between active SLE patients and healthy donors, we employed CD45RA and CD25 as surface markers and carboxyfluorescein diacetatesuccinimidyl ester (CFSE) dilution assay. In addition, multiplex cytokines expression in active SLE patients was assessed using Luminex assay. Here, we showed a significant increase in the frequency of CD45RA(+)FoxP3(low) naive Treg cells (nTreg cells) and CD45RA(-)FoxP3(low) (non-Treg) cells in patients with active SLE. In active SLE patients, the increased proportions of CD45RA(+)FoxP3(low) nTreg cells were positively correlated with the disease based on SLE disease activity index (SLEDAI) and the status of serum anti-dsDNA antibodies. We found that the surface marker combination of CD25(+)CD45RA(+) can be used to defined CD45RA(+)FoxP3(low) nTreg cells for functional assays, wherein nTreg cells from active SLE patients demonstrated defective suppression function. A significant correlation was observed between inflammatory cytokines, such as IL-6, IL-12 and TNFα, and the frequency of nTreg cells. Furthermore, the CD45RA(+)FoxP3(low) nTreg cell subset increased when cultured with SLE serum compared to healthy donor serum, suggesting that the elevated inflammatory cytokines of SLE serum may promote nTreg cell proliferation/expansion. CONCLUSIONS/SIGNIFICANCE: Our results indicate that impaired numbers of functional CD45RA(+)FoxP3(low) naive Treg cell and CD45RA(-)FoxP3(low) non-suppressive T cell subsets in inflammatory conditions may contribute to SLE development. Therefore, analysis of subsets of FoxP3(+) T cells, using a combination of FoxP3, CD25 and CD45RA, rather than whole FoxP3(+) T cells, will help us to better understand the pathogenesis of SLE and may lead to the development of new therapeutic strategies

Régulation du Système de Sécrétion de Type III de Pseudomonas aeruginosa

Pseudomonas aeruginosa is an opportunistic pathogen that causes acute and chronic infections in hospitalized individuals, burn victims, and cystic fibrosis patients. One of the virulence factors most strongly correlated with severe infection both in animal models and in human patients is the type III secretion system (TTSS).We have observed a previously identified protein, PsrA, necessary for full activation of TTSS gene expression in P. aeruginosa. Electrophoretic mobility shift assays showed that recombinant PsrA could bind to the exsCEBA promoter region. Mutant with a deletion in the psrA gene showed a marked decrease in the secretion of the type III effectors and weak resistance to phagocyte-like PLB-985 cells. Taken altogether, these results suggest that PsrA is a newly identified activator that is involved in the expression of the TTSS by enhancing the exsCEBA transcriptional level.In the second time, we found that an inhibitory signal, which is similar but not known quorum sensing signal, produced in the stationary phase culture supernatant, can repress in vitro the expression of TTSS. The analysis of thousands of transposon insertion mutants showed that the production of this signal might depend on the tryptophan, which is the precursor of many metabolites, such as indole-3-acetic acid (IAA). IAA sodium salt (IAA-Na) and one of IAA-like compound, 1-naphthaleneacetic acid potassium salt (NAA-K) can indeed inhibit the expression and the secretion of the TTSS at millimolar concentrations. The precise identification of this signal requires more investigations.Pseudomonas aeruginosa est un pathogène opportuniste responsable d'infections graves chez les personnes immunodéprimées, les grands brûlés et les patients atteints de la mucoviscidose. Cette pathogénicité repose sur de nombreux facteurs de virulence dont le système de sécrétion de type III (SSTT).Nous avons observé une protéine précédemment identifiée, PsrA, nécessaire pour la pleine activation de l'expression du SSTT chez P. aeruginosa. Les analyses par retard de migration électrophorétique de fragments du promoteur de l'operon régulateur exsCEBA ont montré que la protéine recombinante PsrA pourrait se fixer sur celui-ci. Le mutant DpsrA a montré une diminution marquée de la sécrétion des effecteurs de type III et une faible résistance à la bactéricidie par des cellules de type phagocytaires, PLB-985. L'ensemble des résultats suggèrent que PsrA est un nouvel activateur qui est impliqué dans l'expression du SSTT en augmentant le niveau de la transcription d'exsCEBA.Dans un second temps, nous avons mis en évidence qu'un signal inhibiteur, de type quorum sensing inconnu et produit dans la phase stationnaire de la culture, peut réprimer l'expression du SSTT in vitro. L'analyse de milliers de mutants de transposition a montré que la production de ce signal dépend du tryptophane, qui est le précurseur de nombreux métabolites dont l'acide d'indole-3-acétic (IAA). IAA-Na et un autre membre de cette famille de molécules, le acide 1-naphthalenacétique (NAA-K) aux concentrations millimolaires peuvent en effet inhiber l'expression et la sécrétion du SSTT. L'identification précise de ce signal nécessite des investigations plus poussées

Régulation du Système de Sécrétion de Type III de Pseudomonas aeruginosa

Pseudomonas aeruginosa is an opportunistic pathogen that causes acute and chronic infections in hospitalized individuals, burn victims, and cystic fibrosis patients. One of the virulence factors most strongly correlated with severe infection both in animal models and in human patients is the type III secretion system (TTSS).We have observed a previously identified protein, PsrA, necessary for full activation of TTSS gene expression in P. aeruginosa. Electrophoretic mobility shift assays showed that recombinant PsrA could bind to the exsCEBA promoter region. Mutant with a deletion in the psrA gene showed a marked decrease in the secretion of the type III effectors and weak resistance to phagocyte-like PLB-985 cells. Taken altogether, these results suggest that PsrA is a newly identified activator that is involved in the expression of the TTSS by enhancing the exsCEBA transcriptional level.In the second time, we found that an inhibitory signal, which is similar but not known quorum sensing signal, produced in the stationary phase culture supernatant, can repress in vitro the expression of TTSS. The analysis of thousands of transposon insertion mutants showed that the production of this signal might depend on the tryptophan, which is the precursor of many metabolites, such as indole-3-acetic acid (IAA). IAA sodium salt (IAA-Na) and one of IAA-like compound, 1-naphthaleneacetic acid potassium salt (NAA-K) can indeed inhibit the expression and the secretion of the TTSS at millimolar concentrations. The precise identification of this signal requires more investigations.Pseudomonas aeruginosa est un pathogène opportuniste responsable d'infections graves chez les personnes immunodéprimées, les grands brûlés et les patients atteints de la mucoviscidose. Cette pathogénicité repose sur de nombreux facteurs de virulence dont le système de sécrétion de type III (SSTT).Nous avons observé une protéine précédemment identifiée, PsrA, nécessaire pour la pleine activation de l'expression du SSTT chez P. aeruginosa. Les analyses par retard de migration électrophorétique de fragments du promoteur de l'operon régulateur exsCEBA ont montré que la protéine recombinante PsrA pourrait se fixer sur celui-ci. Le mutant DpsrA a montré une diminution marquée de la sécrétion des effecteurs de type III et une faible résistance à la bactéricidie par des cellules de type phagocytaires, PLB-985. L'ensemble des résultats suggèrent que PsrA est un nouvel activateur qui est impliqué dans l'expression du SSTT en augmentant le niveau de la transcription d'exsCEBA.Dans un second temps, nous avons mis en évidence qu'un signal inhibiteur, de type quorum sensing inconnu et produit dans la phase stationnaire de la culture, peut réprimer l'expression du SSTT in vitro. L'analyse de milliers de mutants de transposition a montré que la production de ce signal dépend du tryptophane, qui est le précurseur de nombreux métabolites dont l'acide d'indole-3-acétic (IAA). IAA-Na et un autre membre de cette famille de molécules, le acide 1-naphthalenacétique (NAA-K) aux concentrations millimolaires peuvent en effet inhiber l'expression et la sécrétion du SSTT. L'identification précise de ce signal nécessite des investigations plus poussées

Régulation du système de sécrétion de type III de Pseudomonas aeruginosa

Pseudomonas aeruginosa est un pathogène opportuniste responsable d'infections graves chez les personnes immunodéprimées, les grands brûlés et les patients atteints de la mucoviscidose. Cette pathogénicité repose sur de nombreux facteurs de virulence dont le système de sécrétion de type III (SSTT).Nous avons observé une protéine précédemment identifiée, PsrA, nécessaire pour la pleine activation de l'expression du SSTT chez P. aeruginosa. Les analyses par retard de migration électrophorétique de fragments du promoteur de l'operon régulateur exsCEBA ont montré que la protéine recombinante PsrA pourrait se fixer sur celui-ci. Le mutant DpsrA a montré une diminution marquée de la sécrétion des effecteurs de type III et une faible résistance à la bactéricidie par des cellules de type phagocytaires, PLB-985. L'ensemble des résultats suggèrent que PsrA est un nouvel activateur qui est impliqué dans l'expression du SSTT en augmentant le niveau de la transcription d'exsCEBA.Dans un second temps, nous avons mis en évidence qu'un signal inhibiteur, de type quorum sensing inconnu et produit dans la phase stationnaire de la culture, peut réprimer l'expression du SSTT in vitro. L'analyse de milliers de mutants de transposition a montré que la production de ce signal dépend du tryptophane, qui est le précurseur de nombreux métabolites dont l'acide d'indole-3-acétic (IAA). IAA-Na et un autre membre de cette famille de molécules, le acide 1-naphthalenacétique (NAA-K) aux concentrations millimolaires peuvent en effet inhiber l'expression et la sécrétion du SSTT. L'identification précise de ce signal nécessite des investigations plus poussées.GRENOBLE1-BU Sciences (384212103) / SudocSudocFranceF

Needle length control and the secretion substrate specificity switch are only loosely coupled in the type III secretion apparatus of Shigella

The type III secretion apparatus (T3SA), which is evolutionarily and structurally related to the bacterial flagellar hook basal body, is a key virulence factor used by many Gram-negative bacteria to inject effector proteins into host cells. A hollow extracellular needle forms the injection conduit of the T3SA. Its length is tightly controlled to match specific structures at the bacterial and host-cell surfaces but how this occurs remains incompletely understood. The needle is topped by a tip complex, which senses the host cell and inserts as a translocation pore in the host membrane when secretion is activated. The interaction of two conserved proteins, inner-membrane Spa40 and secreted Spa32, respectively, in Shigella, is proposed to regulate needle length and to flick a type III secretion substrate specificity switch from needle components/Spa32 to translocator/effector substrates. We found that, as in T3SAs from other species, substitution N257A within the conserved cytoplasmic NPTH region in Spa40 prevented its autocleavage and substrate specificity switching. Yet, the spa40(N257A) mutant made only slightly longer needles with a few needle tip complexes, although it could not form translocation pores. On the other hand, Δspa32, which makes extremely long needles and also formed only few tip complexes, could still form some translocation pores, indicating that it could switch substrate specificity to some extent. Therefore, loss of needle length control and defects in secretion specificity switching are not tightly coupled in either a Δspa32 mutant or a spa40(N257A) mutant